Fasting insulin: what your result means.

Fasting insulin measures how hard your pancreas is working to keep blood glucose normal. Rising insulin is among the earliest measurable signs of insulin resistance, often a decade or more before glucose or HbA1c become abnormal.

Why Fasting insulin matters

In early insulin resistance, glucose looks normal precisely because insulin is compensating. Measuring the compensation itself unmasks metabolic dysfunction at its most reversible stage, which is why preventative medicine treats fasting insulin as an early-warning marker rather than waiting for glucose to fail.

Associated risks when out of range: Insulin resistance. Metabolic syndrome. Fatty liver.

What the clinical evidence shows

The evidence base behind how the HodieLabs Evidence-Based Clinical Library interprets Fasting insulin, from randomised trials, prospective cohorts and genetic (Mendelian randomisation) studies. Full citations in the reference list below.

• Whitehall II cohort (Tabák et al. The Lancet 2009): insulin sensitivity deteriorated steeply for at least five years before diabetes diagnosis while glucose remained near-normal, direct evidence that insulin measures reveal the disease process earliest.
• San Antonio / metabolic cohort evidence (Facchini et al. JCEM 2001): insulin-resistant adults had markedly higher rates of hypertension, coronary disease, stroke and type 2 diabetes over follow-up. Insulin resistance predicted age-related disease in people who were not yet diabetic.
• Physiology consensus (DeFronzo & Tripathy, Diabetes Care 2009): skeletal-muscle insulin resistance is detectable decades before beta-cell failure, and compensatory hyperinsulinaemia, visible as elevated fasting insulin, is its earliest routine laboratory signature.

Evidence-based reference ranges

The HodieLabs Evidence-Based Clinical Library interprets Fasting insulin against published clinical authority standards, never arbitrary "optimal" ranges. Measured in mIU/L:

Clinical interpretation

• The earliest metabolic dysfunction marker. Insulin rises years before glucose becomes abnormal.
• Interpret with HOMA-IR and TG/HDL ratio for a complete insulin resistance picture.
• Fasting insulin >10 mU/L warrants metabolic investigation even if glucose is normal.
• Note: the 2.0–5.0 mIU/L "optimal" tier reflects observational metabolic health literature on strong insulin sensitivity. It is a useful metabolic coaching target but is not equivalent to a society-endorsed diagnostic band.

What improves it: the evidence-based levers

• Reduce refined carbs
• Resistance training
• Time-restricted eating
• Visceral fat reduction

Recommended testing frequency: Annual, as part of a comprehensive panel. Single markers are always interpreted in context.

How Fasting insulin testing works at HodieLabs

Fasting insulin is measured in every Health Blueprint at our Melbourne Preventative Health & Longevity Clinic, interpreted by a doctor against the guideline-cited ranges above and tracked over time through your HodieLabs membership.

References

1. Tabák AG, et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes (Whitehall II). Lancet. 2009;373:2215–2221.
2. Facchini FS, et al. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab. 2001;86:3574–3578.
3. DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009;32(Suppl 2):S157–S163.

This page is general information from the HodieLabs Evidence-Based Clinical Library, not medical advice. Speak with your GP about what testing and care is appropriate for you.